Citadel Advisors’s Transcat TRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.23M Buy
+44,000
New +$3.1M ﹤0.01% 5115
2025
Q4
Sell
-6,000
Closed -$439K 14094
2025
Q3
$439K Sell
6,000
-14,300
-70% -$1.15M ﹤0.01% 9452
2025
Q2
$1.74M Buy
20,300
+19,000
+1,462% +$1.55M ﹤0.01% 5965
2025
Q1
$96.8K Buy
1,300
+600
+86% +$50.3K ﹤0.01% 11523
2024
Q4
$74K Buy
700
+300
+75% +$33.3K ﹤0.01% 11886
2024
Q3
$48.3K Buy
+400
New +$49.7K ﹤0.01% 11951

Other funds holding TRNS

Citadel Advisors's TRNS Position: Q1 2026 in Review

Citadel Advisors reduced its Transcat (TRNS) stake by 63% in Q1 2026, selling an estimated $4.53M and leaving 37,697 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #5426.

Citadel Advisors first reported a position in TRNS in Q1 2021 and has held it in 18 quarters since. The position peaked at $6.34M in Q2 2025. 159 funds tracked by Wall St. Rank hold TRNS as of Q1 2026.

  • Citadel Advisors held 37,697 shares of Transcat worth $2.77M as of Q1 2026.
  • Citadel Advisors sold 64,384 Transcat shares in Q1 2026, an estimated $4.53M.
  • Transcat made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5426 holding.
  • Citadel Advisors first reported a position in Transcat in Q1 2021 and has held it in 18 quarters since.
  • Citadel Advisors's Transcat position peaked at $6.34M in Q2 2025.
  • 159 funds tracked by Wall St. Rank held Transcat as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.